Overview

• HHS Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary told Republican state attorneys general the agency will reexamine mifepristone’s safety and dispensing rules.
• The announcement cites an Ethics and Public Policy Center analysis claiming nearly 11% serious adverse events, a non–peer‑reviewed report that clinicians have criticized for opaque methods and expansive definitions.
• Medication abortion now accounts for more than 60% of U.S. abortions, with about one in four provided via telehealth and many protected under state shield laws.
• Republican-led efforts continue on multiple fronts, including a renewed push to revive litigation over FDA actions, Louisiana’s controlled‑substance classification, and a new Texas law enabling private lawsuits of at least $100,000 over abortion pill distribution.
• Access networks remain robust, with telehealth providers, offshore services like Aid Access, and e‑commerce sources mailing pills into restricted states as documented by advocates such as Plan C.